389 related articles for article (PubMed ID: 17666093)
1. Growth hormone (GH) treatment reduces peripheral thyroid hormone action in girls with Turner syndrome.
Susperreguy S; Miras MB; Montesinos MM; Mascanfroni ID; Muñoz L; Sobrero G; Silvano L; Masini-Repiso AM; Coleoni AH; Targovnik HM; Pellizas CG
Clin Endocrinol (Oxf); 2007 Oct; 67(4):629-36. PubMed ID: 17666093
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone treatment in children with idiopathic short stature: correlation of growth response with peripheral thyroid hormone action.
Susperreguy S; Muñoz L; Tkalenko NY; Mascanfroni ID; Alamino VA; Montesinos MM; Masini-Repiso AM; Miras MB; Pellizas CG
Clin Endocrinol (Oxf); 2011 Mar; 74(3):346-53. PubMed ID: 21091751
[TBL] [Abstract][Full Text] [Related]
3. Sex hormone-binding globulin as a marker of the effect of hormonal treatment in Turner's syndrome.
Hampl R; Snajderova M; Lebl J; Lisa L; Dvorakova M; Hill M; Sulcova J; Starka L
Endocr Regul; 2001 Mar; 35(1):17-24. PubMed ID: 11308992
[TBL] [Abstract][Full Text] [Related]
4. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
[TBL] [Abstract][Full Text] [Related]
6. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome.
Gravholt CH; Hjerrild BE; Naeraa RW; Engbaek F; Mosekilde L; Christiansen JS
Clin Endocrinol (Oxf); 2005 May; 62(5):616-22. PubMed ID: 15853835
[TBL] [Abstract][Full Text] [Related]
7. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of cDNAs for hormones and/or receptors of growth hormone, insulin-like growth factor-I, thyroid hormone, and corticosteroid and the gender-, tissue-, and developmental-specific expression of their mRNA transcripts in fathead minnow (Pimephales promelas).
Filby AL; Tyler CR
Gen Comp Endocrinol; 2007 Jan; 150(1):151-63. PubMed ID: 16970945
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of receptors for thyroid hormone and insulin-like growth factor-I during reconstitution after allogeneic hematopoietic stem cell transplantation.
Omazic B; Näsman-Björk I; Johansson J; Hentschke P; Mattsson J; Permert J; Lundkvist I
Bone Marrow Transplant; 2001 Jun; 27(11):1163-71. PubMed ID: 11551027
[TBL] [Abstract][Full Text] [Related]
10. [The effect of growth hormone therapy on thyroid parameters].
Lebl J; Pechová M; Kolousková S; Snajderová M
Cesk Pediatr; 1994; 49(1):34-7. PubMed ID: 8124749
[TBL] [Abstract][Full Text] [Related]
11. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone.
Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H
J Clin Endocrinol Metab; 1996 Feb; 81(2):536-41. PubMed ID: 8636264
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
Cutfield WS; Lundgren F
Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
[TBL] [Abstract][Full Text] [Related]
13. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.
Bannink EM; van Sassen C; van Buuren S; de Jong FH; Lequin M; Mulder PG; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2009 Feb; 70(2):265-73. PubMed ID: 19200215
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
Akin F; Yaylali GF; Turgut S; Kaptanoglu B
Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
[TBL] [Abstract][Full Text] [Related]
15. Analysis of thyroid hormone receptor betaA mRNA expression in Xenopus laevis tadpoles as a means to detect agonism and antagonism of thyroid hormone action.
Opitz R; Lutz I; Nguyen NH; Scanlan TS; Kloas W
Toxicol Appl Pharmacol; 2006 Apr; 212(1):1-13. PubMed ID: 16040072
[TBL] [Abstract][Full Text] [Related]
16. Isolation of the alligator (Alligator mississippiensis) thyroid hormone receptor alpha and beta transcripts and their responsiveness to thyroid stimulating hormone.
Helbing CC; Crump K; Bailey CM; Kohno S; Veldhoen N; Bryan T; Bermudez D; Guillette LJ
Gen Comp Endocrinol; 2006 Nov; 149(2):141-50. PubMed ID: 16884722
[TBL] [Abstract][Full Text] [Related]
17. Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism?
Giavoli C; Porretti S; Ferrante E; Cappiello V; Ronchi CL; Travaglini P; Epaminonda P; Arosio M; Beck-Peccoz P
Clin Endocrinol (Oxf); 2003 Dec; 59(6):806-10. PubMed ID: 14974926
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences.
Bannink EM; van der Palen RL; Mulder PG; de Muinck Keizer-Schrama SM
Horm Res; 2009; 71(6):343-9. PubMed ID: 19506392
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone treatment of girls with Turner syndrome: the National Cooperative Growth Study experience.
Plotnick L; Attie KM; Blethen SL; Sy JP
Pediatrics; 1998 Aug; 102(2 Pt 3):479-81. PubMed ID: 9685447
[TBL] [Abstract][Full Text] [Related]
20. The effect of 3,5,3'-triiodothyronine supplementation on zebrafish (Danio rerio) embryonic development and expression of iodothyronine deiodinases and thyroid hormone receptors.
Walpita CN; Van der Geyten S; Rurangwa E; Darras VM
Gen Comp Endocrinol; 2007; 152(2-3):206-14. PubMed ID: 17418841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
